Literature DB >> 21436066

Immunotherapeutic effects of IL-7 during a chronic viral infection in mice.

Som G Nanjappa1, Eui Ho Kim, M Suresh.   

Abstract

Viral persistence during chronic viral infections is associated with a progressive loss of T-cell effector function called functional exhaustion. There is therefore a need to develop immunotherapies to remediate the functional deficits of T cells during these infections. We investigated the immunotherapeutic effects of IL-7 during chronic lymphocytic choriomeningitis virus infection in mice. Our results showed that the effects of IL-7 on T cells depend on the viral load, timing, and duration of treatment during the course of the infection. We document that the effectiveness of IL-7 was constrained by high viral load early in the infection, but treatment for at least 3 weeks during declining viral titers mitigated the programmed contraction of CD8 T cells, markedly enhanced the number of high-quality polyfunctional virus-specific CD8 T cells with a nonexhausted phenotype, and accelerated viral control. Mechanistically, the enhancement of CD8 T-cell responses by IL-7 was associated with increased proliferation and induction of Bcl-2, but not with altered levels of PD-1 or Cbl-b. In summary, our results strongly suggest that IL-7 therapy is a potential strategy to bolster the quality and quantity of T-cell responses in patients with chronic viral infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436066      PMCID: PMC3109537          DOI: 10.1182/blood-2010-12-323154

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool.

Authors:  Fraia Melchionda; Terry J Fry; Matthew J Milliron; Melissa A McKirdy; Yutaka Tagaya; Crystal L Mackall
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

2.  Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity.

Authors:  Mohammed Shamim; Som G Nanjappa; Anju Singh; Erin Hemmila Plisch; Scott E LeBlanc; Jane Walent; John Svaren; Christine Seroogy; M Suresh
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

3.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

4.  Interleukin-10 determines viral clearance or persistence in vivo.

Authors:  David G Brooks; Matthew J Trifilo; Kurt H Edelmann; Luc Teyton; Dorian B McGavern; Michael B A Oldstone
Journal:  Nat Med       Date:  2006-10-15       Impact factor: 53.440

5.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

Authors:  Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

6.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

Review 7.  IL-7: maintaining T-cell memory and achieving homeostasis.

Authors:  Linda M Bradley; Laura Haynes; Susan L Swain
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

8.  Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

Authors:  E John Wherry; Sang-Jun Ha; Susan M Kaech; W Nicholas Haining; Surojit Sarkar; Vandana Kalia; Shruti Subramaniam; Joseph N Blattman; Daniel L Barber; Rafi Ahmed
Journal:  Immunity       Date:  2007-10-18       Impact factor: 31.745

9.  Expression of IL-7 receptor alpha is necessary but not sufficient for the formation of memory CD8 T cells during viral infection.

Authors:  Timothy W Hand; Michel Morre; Susan M Kaech
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

10.  Resolution of a chronic viral infection after interleukin-10 receptor blockade.

Authors:  Mette Ejrnaes; Christophe M Filippi; Marianne M Martinic; Eleanor M Ling; Lisa M Togher; Shane Crotty; Matthias G von Herrath
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

View more
  26 in total

Review 1.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.

Authors:  Yuichiro Shindo; Anja G Fuchs; Christopher G Davis; Tim Eitas; Jacqueline Unsinger; Carey-Ann D Burnham; Jonathan M Green; Michel Morre; Grant V Bochicchio; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2016-09-14       Impact factor: 4.962

Review 3.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 4.  T cell exhaustion during persistent viral infections.

Authors:  Shannon M Kahan; E John Wherry; Allan J Zajac
Journal:  Virology       Date:  2015-01-22       Impact factor: 3.616

Review 5.  Treatment of hepatitis B virus: an update.

Authors:  Haley Ward; Lydia Tang; Bhawna Poonia; Shyam Kottilil
Journal:  Future Microbiol       Date:  2016-11-18       Impact factor: 3.165

6.  Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy.

Authors:  Chao Wang; Maria I Edilova; Lisa E Wagar; Shariq Mujib; Meromit Singer; Nicole F Bernard; Thérèse Croughs; Michael M Lederman; Irini Sereti; Margaret A Fischl; Elisabeth Kremmer; Mario Ostrowski; Jean-Pierre Routy; Tania H Watts
Journal:  J Immunol       Date:  2017-12-08       Impact factor: 5.422

7.  CBLB Constrains Inactivated Vaccine-Induced CD8+ T Cell Responses and Immunity against Lethal Fungal Pneumonia.

Authors:  Som G Nanjappa; Srinivasu Mudalagiriyappa; J Scott Fites; M Suresh; Bruce S Klein
Journal:  J Immunol       Date:  2018-07-27       Impact factor: 5.422

Review 8.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

9.  PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.

Authors:  Erin E West; Hyun-Tak Jin; Ata-Ur Rasheed; Pablo Penaloza-Macmaster; Sang-Jun Ha; Wendy G Tan; Ben Youngblood; Gordon J Freeman; Kendall A Smith; Rafi Ahmed
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

Review 10.  Anti-viral CD8 T cells and the cytokines that they love.

Authors:  Maureen A Cox; Shannon M Kahan; Allan J Zajac
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.